Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H30FNO4 |
| Molecular Weight | 391.4763 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NC[C@H](O)COC1=CC=C(OCCOCCC2=CC=C(F)C=C2)C=C1
InChI
InChIKey=CYCXZGUVPDRYLG-FQEVSTJZSA-N
InChI=1S/C22H30FNO4/c1-17(2)24-15-20(25)16-28-22-9-7-21(8-10-22)27-14-13-26-12-11-18-3-5-19(23)6-4-18/h3-10,17,20,24-25H,11-16H2,1-2H3/t20-/m0/s1
| Molecular Formula | C22H30FNO4 |
| Molecular Weight | 391.4763 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [The effect of propranolol and flusoxolol on the lysosomal enzyme activity of the rat ventricular myocardium]. | 1992-09-01 |
|
| Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives. | 1985 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2877883
It was given to 6 healthy volunteers in a single dose, 40 mg, and then in multiple doses, 40 mg daily for 8 days.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:09:12 GMT 2025
by
admin
on
Mon Mar 31 18:09:12 GMT 2025
|
| Record UNII |
1GPL60IRCI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5375
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY | |||
|
1GPL60IRCI
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY | |||
|
CHEMBL1742476
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY | |||
|
DTXSID70232952
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY | |||
|
71765
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY | |||
|
100000080952
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY | |||
|
Flusoxolol
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY | |||
|
84057-96-5
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY | |||
|
SUB07753MIG
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY | |||
|
C73018
Created by
admin on Mon Mar 31 18:09:12 GMT 2025 , Edited by admin on Mon Mar 31 18:09:12 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |